United States set
Menu Shopping cart $0 Search
Distributed product


  • Regulatory status:RUO
  • Type:Competitive ELISA, Immobilized antigen
  • Other names:Symmetric Dimethylarginine
  • Species:Dog, Feline
This product is not available in United States!
Cat. No. Size Price

EA203/96 96 wells (1 kit)
PubMed Product Details
Technical Data


Competitive ELISA, Immobilized antigen


Serum, Plasma-EDTA

Sample Requirements

20 μl/well


At ambient temperature. Upon receipt, store the product at the temperature recommended below.


Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Range

0.2–3.0 µmol/l

Limit of Detection

0.03 μmol/l

Intra-assay (Within-Run)

Cat: 5,7
Dog: 5,9%

Inter-assay (Run-to-Run)

Cat: 8,1%
Dog: 8,5%

Spiking Recovery

Cat: 97% (90-104%)
Dog: 104%

Dilution Linearity

Cat: 96%
Dog: 92%



  • Disposable gloves should be used.
  • Material of animal origin used in the preparation of the kit has been obtained from animals certified as healthy but these materiále should be handled as potentially infectious.

Research topic

Renal disease, Animal studies


SDMA is eliminated from the body exclusively by renal excretion; therefore SDMA plasma concentration is tightly related to renal function. Elevated SDMA levels may prospectively indicate future risk of cardiovascular disease and mortality independently of the level of renal impairment.

Product References (3)


  • Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, Fliser D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis. Nephrol Dial Transplant. 2006 Sep;21(9):2446-51. doi: 10.1093/ndt/gfl292. Epub 2006 Jun 9. PubMed PMID: 16766542. See more on PubMed
  • Bode-Böger SM, Scalera F, Kielstein JT, Martens-Lobenhoffer J, Breithardt G, Fobker M, Reinecke H. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol. 2006 Apr;17(4):1128-34. doi: 10.1681/ASN.2005101119. Epub 2006 Feb 15. PubMed PMID: 16481412. See more on PubMed
  • Wanby P, Teerlink T, Brudin L, Brattström L, Nilsson I, Palmqvist P, Carlsson M. Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population. Atherosclerosis. 2006 Apr;185(2):271-7. doi: 10.1016/j.atherosclerosis.2005.06.033. Epub 2005 Aug 1. PubMed PMID: 16055131. See more on PubMed
Related Products Docs